🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Data from 40 patients are planned to be included in the study to randomize ...
Status
Recruiting
Location
Kulyova Svetlana
Start Date
2021-05-20
Trial ID
NCT06669013
Treatments Being Tested
Safety evaluation and initial efficacy evaluation will be conducted in a gr...
Status
Recruiting
Location
University Children Hospital
Start Date
2021-12-01
Trial ID
NCT05272371
Treatments Being Tested
This partially randomized phase III trial studies isotretinoin with dinutux...
Status
Completed
Location
Children's Hospital of Alabama
Start Date
2001-10-26
Trial ID
NCT00026312
A prospective open label, multicenter study to evaluate the feasibility and...
Status
Recruiting
Location
University of Alabama/Children's of Alabama
Start Date
2015-09
Trial ID
NCT02559778
Treatments Being Tested
This phase I trial is to find out the best dose, possible benefits and/or s...
Status
Terminated
Location
Children's Hospital Los Angeles
Start Date
2021-08-31
Trial ID
NCT04751383
The goal of this clinical trial is to to assess the dose level of dinutuxim...
Status
Recruiting
Location
Princess Maxima center for pediatric oncology
Start Date
2025-01-28
Trial ID
NCT06485947
Treatments Being Tested
This is a phase II study looking at patient response to treatment with the ...
Status
Recruiting
Location
Children's Hospital Los Angeles
Start Date
2024-12-16
Trial ID
NCT06450041
Treatments Being Tested
Although the five year survival rate of children with high risk neuroblasto...
Status
Terminated
Location
University of Cologne
Start Date
2015-11
Trial ID
NCT02641782
Treatments Being Tested
This is an international multicenter, open-label, randomized phase III tria...
Status
Recruiting
Location
Sydney children Hospital
Start Date
2019-11-05
Trial ID
NCT04221035
This NANT trial will determine the maximum tolerated dose (MTD) of autologo...
Status
Active Not Recruiting
Location
Children's Hospital Los Angeles
Start Date
2019-01-14
Trial ID
NCT02573896
Treatments Being Tested